
|Articles|July 1, 1998
Supplements and Featured Publications
- New and Emerging Therapies in the Treatment of Hypertension and Congestive Heart Failure
- Volume 4
- Issue 7 Suppl
Rationale for Angiotensin Receptor Blockers in Congestive Heart Failure
Author(s)Alan H. Gradman, MD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Gene Polymorphism Influences Response to Angiotensin Blockadeover 27 years ago
New Drug Class Offers Benefits in Heart FailureNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
3
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
4
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
5















































